Happiness Development Group (HAPP) Stock Price, News & Analysis

Company Overview

Happiness Development Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Biotech Group Limited and changed its name to Happiness Development Group Limited in October 2022. Happiness Development Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.

Key Stats

• Today's Range: $0.94 to $0.98
• 50-Day Range: $0.92 to $1.38
• 52-Week Range: $2.08 to $7.40
• Volume: 2,959 shs
• Average Volume: 14,340 shs
• Market Capitalization: $6.82 million
• P/E Ratio: 2.04
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HAPP Stock Analysis - Frequently Asked Questions

How have HAPP shares performed this year?

Happiness Development Group's stock was trading at $1.3150 at the beginning of 2025. Since then, HAPP stock has decreased by 25.4% and is now trading at $0.9810.
View the best growth stocks for 2025 here.

When did Happiness Development Group's stock split?

Happiness Development Group's stock reverse split on Tuesday, October 11th 2022. The 1-20 reverse split was announced on Tuesday, October 11th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, October 11th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Does Happiness Development Group have any subsidiaries?

Happiness Development Group subsidiaries include Fujian Happiness Biotech Co., Happiness Biology Technology Group Ltd., Happiness (Nanping) Biotech Co., and Shunchang Happiness Nutraceutical Co..

When did Happiness Development Group IPO?

Happiness Development Group (HAPP) raised $11 million in an IPO on Friday, October 25th 2019. The company issued 2,000,000 shares at a price of $5.50 per share. Univest Securities served as the underwriter for the IPO and WestPark Capital, Newbridge Securities and Zivest Global were co-managers.

How do I buy shares of Happiness Development Group?

Shares of HAPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Happiness Development Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Happiness Development Group investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Meta Platforms (META), Tesla (TSLA), Johnson & Johnson (JNJ) and NIO (NIO).

Company Calendar

• Today: 5/29/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Multi-Sector Conglomerates
• Industry: Medicinals & botanicals
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HAPP
• CIK: 1751876
• Web: www.happ.org.cn
• Phone: 86-059-9782-8808
• Fax: N/A
• Employees: 215
• Year Founded: 2018

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 2.10
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.01
• Quick Ratio: 1.94

Sales & Book Value

• Annual Sales: $95.59 million
• Price / Sales: 0.07
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $19.57 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 6,955,000
• Free Float: 5,871,000
• Market Cap: $7.02 million
• Optionable: Not Optionable
• Beta: 0.23